ALB
Albemarle
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 4
Sell signal 1
dividend princes
Dividend Aristocrat
Upward Gap
Revenue Beats Expectation
EPS Below Expectations
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About ALB
Albemarle Corporation
A global specialty chemicals company with leading positions in lithium, bromine and catalysts
4250 Congress Street, Suite 900, Charlotte, North Carolina 28209
--
Founded in Virginia in 1993, Albemarle Corporation is an industry-leading global R & D, manufacturing distributor of precision engineering specialty chemicals. Product areas cover consumer electronics, petroleum refining, utilities, packaging, construction, automotive/transportation, pharmaceuticals, crop protection, food safety and custom chemical services. The company is committed to global sustainability and highly accountable ecological practices and solutions under three business segments. The company believes that with the guarantee of commercial and geographical diversity, professional technology, flexible and low-cost global manufacturing base and experienced management team, the company can continue to maintain its market leading position in the specialized chemical industry. The company's operation and management are mainly in three aspects: polymer solutions, catalysts and fine chemistry.
Company Financials
EPS
ALB has released its 2024 Q4 earnings. EPS was reported at -1.09, versus the expected -0.67, missing expectations. The chart below visualizes how ALB has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
ALB has released its 2024 Q4 earnings report, with revenue of 1.23B, reflecting a YoY change of -47.72%, and net profit of 85.11M, showing a YoY change of 114.11%. The Sankey diagram below clearly presents ALB’s revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available